Next Article in Journal
Nutritional Dermatology: Optimizing Dietary Choices for Skin Health
Previous Article in Journal
Micronutrient Deficiencies in Heart Failure and Relationship with Exocrine Pancreatic Insufficiency
Previous Article in Special Issue
Polyphenol Intervention Ameliorates Non-Alcoholic Fatty Liver Disease: An Updated Comprehensive Systematic Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Review

Renal Outcomes and Other Adverse Effects of Cannabinoid Supplementation

by
Ewelina Młynarska
1,*,
Natalia Kustosik
1,
Maja Mejza
1,
Zuzanna Łysoń
1,
Dawid Delebis
1,
Jakub Orliński
1,
Jacek Rysz
2 and
Beata Franczyk
1
1
Department of Nephrocardiology, Medical University of Lodz, 90-549 Lodz, Poland
2
Department of Nephrology, Hypertension and Internal Medicine, Medical University of Lodz, 90-549 Lodz, Poland
*
Author to whom correspondence should be addressed.
Nutrients 2025, 17(1), 59; https://doi.org/10.3390/nu17010059 (registering DOI)
Submission received: 22 October 2024 / Revised: 22 December 2024 / Accepted: 24 December 2024 / Published: 27 December 2024

Abstract

This narrative review explores the benefits and risks of cannabinoids in kidney health, particularly in individuals with pre-existing renal conditions. It discusses the roles of cannabinoid receptor ligands (phytocannabinoids, synthetic cannabinoids, and endocannabinoids) in kidney physiology. The metabolism and excretion of these substances are also highlighted, with partial elimination occurring via the kidneys. The effects of cannabinoids on kidney function are examined, emphasizing both their potential to offer nephroprotection and the risks they may pose, such as cannabinoid hyperemesis syndrome and ischemia-reperfusion injury. These complexities underscore the intricate interactions between cannabinoids and renal health. Furthermore, this review highlights the association between chronic synthetic cannabinoid use and acute kidney injury, stressing the need for further research into their mechanisms and risks. This article also highlights the growing prevalence of edible cannabis and hemp seed consumption, emphasizing their nutritional benefits, legal regulations, and challenges such as inconsistent labeling, potential health risks, and implications for kidney health. The review delves into the roles of CB1 and CB2 receptors in diabetic nephropathy, chronic kidney disease, and obesity-related kidney dysfunction, discussing the therapeutic potential of CB2 agonists and CB1 antagonists. Additionally, it examines the potential diuretic and anti-inflammatory effects of cannabinoids in preventing kidney stones, suggesting that cannabinoids could reduce crystal retention and lower the risk of stone formation. Cannabinoids’ effects on kidneys depend heavily on the characteristics of individual substances, as synthetic cannabinoids pose a major threat to the health of users. Cannabinoids offer therapeutic potential but require more research to confirm their benefits. Distinguishing between therapeutic cannabinoids and harmful synthetic variants is crucial for safe clinical application.
Keywords: phytocannabinoids; endocannabinoids; synthetic cannabinoids; cannabinoid supplementation; renal pathology; acute kidney disease; kidney stone disease; diabetic nephropathy; chronic kidney disease; novel therapies; cannabinoid receptors phytocannabinoids; endocannabinoids; synthetic cannabinoids; cannabinoid supplementation; renal pathology; acute kidney disease; kidney stone disease; diabetic nephropathy; chronic kidney disease; novel therapies; cannabinoid receptors

Share and Cite

MDPI and ACS Style

Młynarska, E.; Kustosik, N.; Mejza, M.; Łysoń, Z.; Delebis, D.; Orliński, J.; Rysz, J.; Franczyk, B. Renal Outcomes and Other Adverse Effects of Cannabinoid Supplementation. Nutrients 2025, 17, 59. https://doi.org/10.3390/nu17010059

AMA Style

Młynarska E, Kustosik N, Mejza M, Łysoń Z, Delebis D, Orliński J, Rysz J, Franczyk B. Renal Outcomes and Other Adverse Effects of Cannabinoid Supplementation. Nutrients. 2025; 17(1):59. https://doi.org/10.3390/nu17010059

Chicago/Turabian Style

Młynarska, Ewelina, Natalia Kustosik, Maja Mejza, Zuzanna Łysoń, Dawid Delebis, Jakub Orliński, Jacek Rysz, and Beata Franczyk. 2025. "Renal Outcomes and Other Adverse Effects of Cannabinoid Supplementation" Nutrients 17, no. 1: 59. https://doi.org/10.3390/nu17010059

APA Style

Młynarska, E., Kustosik, N., Mejza, M., Łysoń, Z., Delebis, D., Orliński, J., Rysz, J., & Franczyk, B. (2025). Renal Outcomes and Other Adverse Effects of Cannabinoid Supplementation. Nutrients, 17(1), 59. https://doi.org/10.3390/nu17010059

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop
  NODES
admin 2
Association 4
Idea 1
idea 1
innovation 2
INTERN 33
Note 8
Project 1
twitter 1
USERS 1